Genomics

Dataset Information

0

Transcriptomics analysis of in vitro NASH models unveils potential adverse effect of elafibranor


ABSTRACT: Non-alcoholic steatohepatitis (NASH) is a life-threatening liver disease for which no drug has been approved. We have previously shown that human-derived hepatic in vitro models can be used to mimic key cellular mechanisms involved in the progression of NASH. In the present study, we first assess the predictive capacity of different in vitro models and then investigate how the reduction of NASH-specific parameters upon treatment with elafibranor, a PPAR-α/δ agonist, correlates with clinical NASH-resolution obtained through bariatric surgery. Whole genome transcriptomics analyses revealed that in vitro NASH models based on primary human hepatocytes (PHH), HepaRG and human skin stem cell-derived hepatic progenitors (hSKP-HPC) exhibit up to 35% overlap with publicly available datasets of liver biopsies of 4 cohorts of NASH patients. Exposure of the in vitro NASH models to elafibranor partially reverses these human-specific transcriptional NASH signatures, with the hSKP-HPC-derived NASH model showing the most sensitive response. NASH-specific transcriptomic changes observed in patients that underwent bariatric surgery correlated with the changes observed in the in vitro NASH models exposed to the PPAR-α/δ agonist. PPARGC1A, PPARA and SIRT1 are shared upstream regulators in the PHH-, HepaRG- and hSKP-HPC NASH models exposed to elafibranor. Activation of these upstream regulators increases the expression of ANGPTL4, PDK4 and PLIN2, while this does not occur in patients that underwent bariatric surgery, suggesting an adverse effect on lipid metabolism. In conclusion, pathologic and therapeutic (anti-)NASH-specific transcriptional responses can be mimicked in PHH, HepaRG and hSKP-HPC, while the latter most sensitively responds to drug testing. PPAR-α/δ agonism adversely modulates pro-steatogenic genes which deserves attention in further studies.

ORGANISM(S): Homo sapiens

PROVIDER: GSE166186 | GEO | 2022/03/16

REPOSITORIES: GEO

Similar Datasets

| E-GEOD-74000 | biostudies-arrayexpress
2020-02-28 | GSE146023 | GEO
2015-11-04 | GSE74000 | GEO
2019-06-01 | GSE126484 | GEO
2015-12-07 | GSE69248 | GEO
2011-07-14 | GSE26207 | GEO
| E-GEOD-26207 | biostudies-arrayexpress
2021-12-08 | ST002057 | MetabolomicsWorkbench
| E-GEOD-37031 | biostudies-arrayexpress
2016-02-16 | GSE67324 | GEO